Literature DB >> 7520898

Inhibitory effect of recombinant fibronectin polypeptides on the adhesion of liver-metastatic lymphoma cells to hepatic sinusoidal endothelial cells and tumor invasion.

J Yoneda1, I Saiki, H Kobayashi, H Fujii, Y Ishizaki, I Kato, M Kiso, A Hasegawa, I Azuma.   

Abstract

We have investigated the inhibitory mechanism of the initial arrest of L5178Y-ML25 lymphoma cells in a target organ (liver) by using recombinant fibronectin fragments with cell- and/or heparin-binding domains (C-274, H-271 or the fusion fragment CH-271). Pretreatment of hepatic sinusoidal endothelial (HSE) cell monolayers with lymphoma cells or their conditioned medium for 4 to 6 h resulted in the enhancement of lymphoma cell adhesion to HSE cell monolayer. The increased tumor adhesiveness was completely abolished by preincubation of the conditioned medium with anti interleukin-1 beta monoclonal antibody (mAb). Synthetic sialyl Le(x) (SLe(x)) as a ligand for endothelial cell leukocyte adhesion molecule-1 (ELAM-1) adhesion receptor and anti ELAM-1 mAb blocked the conditioned medium-induced enhancement of tumor-endothelial cell interaction, while pretreatment of the activated HSE cell monolayer with anti vascular cell adhesion molecule-1 (VCAM-1) mAb did not affect the enhanced tumor cell adhesion. These results indicate that tumor cell interaction with the stimulated HSE cells is mediated by ELAM-1 molecules on HSE cells. However, the expression of SLe(x) and SLe(a) on the tumor surface was not observed by flow cytometric analysis. ELAM-1-mediated enhancement of tumor cell adhesion to HSE monolayer was also inhibited in a concentration-dependent manner by CH-271 fusion polypeptide or the sulfated chitin derivative sulfated carboxymethyl-chitin, which can bind to the heparin-binding domain of CH-271. In addition, CH-271 inhibited not only tumor-endothelium interaction but also tumor cell invasion into reconstituted basement membrane Matrigel in vitro.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7520898      PMCID: PMC5919543          DOI: 10.1111/j.1349-7006.1994.tb02421.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


interleukin‐1β bovine serum albumin Dulbecco's modified Eagle's medium disodium ethylenediamine tetraacetate endothelial cell leukocyte adhesion molecule‐1 fetal bovine serum fluorescein isothiocyanate hepatic sinusoidal endothelial intercellular adhesion molecule‐1 interferon‐γ immunoglobulin G sialylated lacto‐N‐fucopentaose II SLexSSEA‐1, sialylated lacto‐N‐fucopentaose III/stage‐specific embryonic antigen lymphocyte function‐associated antigen‐1 monoclonal antibody phosphate‐buffered saline sulfated carboxymethyl‐chitin tumor necrosis factor‐α vascular cell adhesion molecule‐1 very late activated antigen‐5
  42 in total

1.  Identification of an inducible endothelial-leukocyte adhesion molecule.

Authors:  M P Bevilacqua; J S Pober; D L Mendrick; R S Cotran; M A Gimbrone
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

Review 2.  Microvascular endothelial cell heterogeneity: interactions with leukocytes and tumor cells.

Authors:  P N Belloni; R J Tressler
Journal:  Cancer Metastasis Rev       Date:  1990-02       Impact factor: 9.264

3.  All four internally repetitive domains of pig calpastatin possess inhibitory activities against calpains I and II.

Authors:  M Maki; E Takano; H Mori; A Sato; T Murachi; M Hatanaka
Journal:  FEBS Lett       Date:  1987-10-19       Impact factor: 4.124

4.  A specific cell surface glycoconjugate controlling cell motility: evidence by functional monoclonal antibodies that inhibit cell motility and tumor cell metastasis.

Authors:  M Miyake; S I Hakomori
Journal:  Biochemistry       Date:  1991-04-02       Impact factor: 3.162

5.  An inducible endothelial cell surface glycoprotein mediates melanoma adhesion.

Authors:  G E Rice; M P Bevilacqua
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

6.  Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A.

Authors:  A Takada; K Ohmori; N Takahashi; K Tsuyuoka; A Yago; K Zenita; A Hasegawa; R Kannagi
Journal:  Biochem Biophys Res Commun       Date:  1991-09-16       Impact factor: 3.575

Review 7.  'Seed and soil' revisited: mechanisms of site-specific metastasis.

Authors:  I R Hart
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

8.  Role of type III homology repeats in cell adhesive function within the cell-binding domain of fibronectin.

Authors:  F Kimizuka; Y Ohdate; Y Kawase; T Shimojo; Y Taguchi; K Hashino; S Goto; H Hashi; I Kato; K Sekiguchi
Journal:  J Biol Chem       Date:  1991-02-15       Impact factor: 5.157

9.  Antimetastatic effect by anti-adhesion therapy with cell-adhesive peptide of fibronectin in combination with anticancer drugs.

Authors:  I Saiki; J Yoneda; H Kobayashi; Y Igarashi; H Komazawa; Y Ishizaki; I Kato; I Azuma
Journal:  Jpn J Cancer Res       Date:  1993-03

10.  Inhibitory effect of chitin heparinoids on the lung metastasis of B16-BL6 melanoma.

Authors:  J Murata; I Saiki; S Nishimura; N Nishi; S Tokura; I Azuma
Journal:  Jpn J Cancer Res       Date:  1989-09
View more
  5 in total

1.  Construction of expressing plasmids of recombinant FN polypeptides with bifunctional-domain and the characterization of the products expressed in E. coli.

Authors:  Z Feng; G Zhang; D Li; H Zhang
Journal:  J Tongji Med Univ       Date:  1996

Review 2.  Are selectins involved in metastasis?

Authors:  T Krause; G A Turner
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

3.  Experimental study on therapeutic effect of in vivo expression of Cell I-Hep II recombinant polypeptide of fibronectin on murine H22 hepatocellular carcinoma.

Authors:  Gui-Mei Zhang; Yan Yang; Bo Huang; Hui Xiao; Dong Li; Zuo-Hua Feng
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

Review 4.  Liver endothelial cells: participation in host response to lymphoma metastasis.

Authors:  V Umansky; M Rocha; V Schirrmacher
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

5.  Inhibitory effect of recombinant fibronectin polypeptide CH50 on invasion and metastasis of melanoma B16 cells.

Authors:  Jia Wei; Yiquan Xiong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.